Hostname: page-component-848d4c4894-x24gv Total loading time: 0 Render date: 2024-05-20T06:01:55.728Z Has data issue: false hasContentIssue false
  • English
  • Français

Current Views on Parkinson’s Disease

Published online by Cambridge University Press:  18 September 2015

Donald B. Calne
Donald B. Calne*
Affiliation:
Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, B.C.
*
Division of Neurology, Health Sciences Center Hospital. 2211 Wesbrook Mall, Vancouver, B.C., Canada V6N 1W5.
Rights & Permissions [Opens in a new window]

Summary:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Since the introduction of levodopa therapy, there have been major advances in the understanding and treatment of Parkinson’s disease. However, the problems and limitations associated with this form of treatment are now becoming increasingly apparent. This article reviews some of the current knowledge concerning the etiology and pathophysiology of Parkinson’s disease and discusses some-practical approaches to drug therapy.

Type
Review Article
Information
Canadian Journal of Neurological Sciences , Volume 10 , Issue 1 , February 1983 , pp. 11 - 15
Copyright
Copyright © Canadian Neurological Sciences Federation 1983

References

Agid, Y., Ruberg, M., Dubois, G. and Javoy-Agid, F. (1983). Biochemical substrates of mental disturbances in parkinson disease. Proceedings of the VII International Symposium on Parkinson Disease, Frankfurt. Advances in Neurology, Raven Press, New York. (In press).Google Scholar
Ambani, L.M., Van Woert, M.H. and Murphy, S. (1975). Brain peroxidase and catalase in Parkinson disease. Archives of Neurology 32: 114–118.CrossRefGoogle ScholarPubMed
Barbeau, A. and Pourcher, E. (1982). New Data on the Genetics of Parkinson’s Disease. Canadian Journal of Neurological Sciences 9: 53–60.CrossRefGoogle ScholarPubMed
Baumann, R.J., Jameson, H.D., McKean, H.E., Haack, D.G., Weisberg, L.M. (1980). Cigarette smoking and Parkinson disease: 1. A comparison of cases with matched neighbours. Neurology 30: 839–843.CrossRefGoogle Scholar
Donaldson, J., McGregor, D. and LaBella, F. (1982). Manganese neurotoxicity: a model for free radical mediated neurodegeneration? Canadian Journal of Physiology and Pharmacology 60: 1389–1405.CrossRefGoogle Scholar
Davis, G.C., Williams, A.C., Markey, S.P., Ebert, M.H., Caine, E.D., Reichert, C.M., Kopin, I.J. (1979). Chronic Parkinsonism secondary to intravenous injection of merperidine. Ann. Psychiat. Res. 1: 249–254.CrossRefGoogle Scholar
Duvoisin, R.C. (1981). The cause of Parkinson’s disease. In: Movement Disorders. Edited by Marsden, C.D. and Fahn, S., London: Butterworth Scientific, pp. 8–24.CrossRefGoogle Scholar
Fahn, S. and Calne, D.B. (1978). Considerations in the management of parkinsonism. Neurology 28: 5–7.CrossRefGoogle ScholarPubMed
Hagbarth, K.E., Hagglund, J.V., Wallin, E.U. and Young, R.R. (1981). Grouped spindle and electromyographic responses to abrupt wrist extension movements in man. Journal of Physiology 312: 81–96.CrossRefGoogle ScholarPubMed
Heikkila, R.E. and Cohen, G. (1972). In vivo generation of hydrogen peroxide from 6-hydroxydopamine. Experientia 28: 1197.CrossRefGoogle ScholarPubMed
Hokfelt, T., Johansson, O., Ljungdahl, A., Lundbert, J.M. and Schultzberg, M. (1980). Peptidergic neurones. Nature 284: 515–521.CrossRefGoogle ScholarPubMed
Javoy-Agid, F., Ruberg, M., Taquet, H., Bokobza, B., Ajid, Y., Gaspar, P., Berger, B., N’Guyen-Legros, J., Alvarez, C., Gray, F., Eccourolle, R., Scatton, B. and Rouquier, L. (1983). Biochemical neuropathology of Parkinson disease. Proceedings of the VIIth International Symposium of Parkinson’s Disease, Frankfurt. Advances in Neurology, Raven Press, New York. (In press).Google Scholar
Kebabian, J.W. and Calne, D.B. (1979). Multiple receptors for dopamine. Nature (London) 277: 93–96.CrossRefGoogle ScholarPubMed
Kolata, G. (1982). Grafts correct brain damage. Science 217: 342–344.CrossRefGoogle ScholarPubMed
Lee, R.G. and Stein, R.B. (1981). Resetting of tremor by mechanical perturbations: A comparison of essential tremor and parkinsonian tremor. Annals of Neurology 10:523–531.CrossRefGoogle ScholarPubMed
Marsden, C.D. (1982). The mysterious motor function of the basal ganglia: The Robert Wartenberg Lecture. Neurology 32: 514–539.CrossRefGoogle ScholarPubMed
Pelletier, G., Steinbusch, H.W.M. and Verhofstad, A.A.J. (1981). Immunoreactive substance P and serotonin present in the same dense-core vesicles. Nature 293: 71–72.CrossRefGoogle ScholarPubMed
Perlow, M.J., Freed, W.J., Hoffer, B.J., Seiger, A., Olson, L., and Wyatt, R.J. (1979). Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science 204: 643–647.CrossRefGoogle ScholarPubMed
Riederer, P. and Wuketich, St. (1976). Time course of nigrostriatal degeneration in Parkinson’s Disease. Journal of Neural Transmission 38: 277–301.CrossRefGoogle ScholarPubMed
Roy, M., Boyer, L., Barbeau, A. (1982). A prospective study of 50 cases of familial Parkinson’s disease. Paper presented at the VIIth International Symposium on Parkinson’s Disease. Frankfurt, Germany. (In press).Google Scholar
Seeman, P. (1980). Brain dopamine receptors. Pharmacological Reviews, 32(3): 230–287.Google ScholarPubMed
Stern, G., Lees, A. and Shaw, K. (1979). Ergot derivatives without levodopa in parkinsonism. In: Dopaminergic Ergot Derivatives and Motor Function, Edited by Fuxe, K., and Calne, D.B., Oxford: Pergamon Press, pp. 337–341.CrossRefGoogle Scholar
Stoof, J.C. and Kebabian, J.W. (1981). Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature 294: 366–368.CrossRefGoogle ScholarPubMed
Stoof, J.C. and Kebabian, J.W. (1982). Independent in vitro regulation by the D-2 dopamine receptor of dopamine-stimulated efflux of cyclic AMP and K+ stimulated release of acetylcholine from rat neostriatum. Brain Research 250: 263–270.CrossRefGoogle Scholar
Studler, J.M., Javoy-Agid, F., Cesselin, F., Legrand, J.C. and Agid, Y. (1982). CCK-8-Immunoreactivity distribution in human brain: selective decrease in the substantia nigra from parkinsonian patients. Brain Research 243: 176–179.CrossRefGoogle ScholarPubMed
Tatton, W.G., Bawa, P., Bruce, I.C. and Lee, R.G. (1978). Long loop reflexes in monkeys: an interpretative base for human reflexes. In: Cerebral Motor Control in Man: Long Loop Mechanisms. Edited by Desmedt, John E.., Basel, New York: Karger. Progress in clinical neurophysiology, Vol. 4, pp. 229–245.Google Scholar
Tatton, W.G. and Lee, R.G. (1975). Evidence for abnormal long-loop reflexes in rigid parkinsonian patients. Brain Research 100:671–676.CrossRefGoogle ScholarPubMed
Teräväinen, H., Evarts, E. and Calne, D. (1979). Effects of kinesthetic inputs on parkinsonian tremor. In: Advances in Neurology. Edited by Poirier, L.J., Sourkes, T.L. and Bedard, P.J., New York: Raven Press, 24: 161–173.Google Scholar
Tracey, D.J., Walmsley, B. and Brinkman, J. (1980). “Long-loop” reflexes can be obtained in spinal monkeys. Neuroscience Letters 18: 59–65.CrossRefGoogle ScholarPubMed
Ward, C.D., Duvoisin, R.C., Ince, S.E., Nutt, J.D., Eldridge, R. and Calne, D.B. (1983). Parkinson’s Disease in twins and in a set of quadruplets. Neurology, (In press).CrossRefGoogle Scholar